Bjärred, Sweden

Anders Wallenborg

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 125(Granted Patents)


Location History:

  • Trollsjovagen, SE (2018)
  • Bjarred, SE (2019 - 2023)
  • Bjärred, SE (2013 - 2024)
  • Bjärr, SE (2024)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Anders Wallenborg**

Introduction

Anders Wallenborg, a prominent inventor based in Bjärred, Sweden, has made significant contributions to the field of medical technology. With a portfolio of 15 patents, Wallenborg has been at the forefront of innovations, particularly in the area of renal replacement therapy.

Latest Patents

Wallenborg’s latest patents include a groundbreaking system and method for renal replacement therapy. This innovative system features a blood treatment unit seamlessly connected to both a blood circuit and a dialysis fluid circuit. It incorporates a control unit designed to manage the system based on specific control instructions throughout the treatment process, determining important parameters such as indications of membrane fouling. Additionally, it employs automatic anti-fouling measures, facilitating a temporary adjustment of flow rates within the blood circuit and a controlled decrease in ultrafiltration rates, all synchronized for optimal efficiency.

Another noteworthy patent is the apparatus for extracorporeal blood treatment. This advanced treatment apparatus consists of a filtration unit linked to a blood circuit and a dialysate circuit, complemented by a preparation device that regulates the dialysis fluid's composition. It includes a conductivity sensor to monitor the spent dialysis fluid, while a control unit manages the sodium concentration within the dialysis fluid. Notably, this system is designed to maintain a constant conductivity level of the dialysis fluid during circulation, ensuring precise calculations of initial plasma conductivity needed for effective treatment.

Career Highlights

Anders Wallenborg currently works at Gambro Lundia AB, where he has played a key role in pioneering new medical technologies. His commitment to innovation in renal therapy has not only advanced treatment methodologies but has also elevated the standards of patient care in the field of nephrology.

Collaborations

Throughout his career, Wallenborg has collaborated with esteemed colleagues such as Thomas Hertz and Anders Nilsson. Together, they have contributed to the advancement of blood treatment technologies, enhancing the effectiveness and efficiency of renal replacement therapies.

Conclusion

Anders Wallenborg stands as a testament to the impact of innovation in the medical field. His inventions, reflected in his extensive patent portfolio, continue to transform the landscape of renal treatment, offering new hope and solutions for patients worldwide. As he pushes the boundaries of technology at Gambro Lundia AB, Wallenborg's work highlights the vital intersection of healthcare and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…